Adopting Clinical Practice Guidelines for Pharmacologic Management of Acute Spinal Cord Injury from a Developed World Context to a Developing Global Region
© 2022 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons. org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited..
BACKGROUND: Proper utilization of high-quality clinical practice guidelines (CPGs) eliminates the dependence of patients' outcomes on the ability and knowledge of "individual" health care providers and reduces unwarranted variation in care. The aim of this study was to adapt/adopt two CPGs for pharmacologic management of acute spinal cord injury (SCI) using guideline adaptation methods.
METHODS: This study was conducted based on the ADAPTE process. Following establishment of an organizing committee and choosing the health topics, we appraised the quality of the CPGs using the Appraisal of Clinical Guidelines for Research & Evaluation II (AGREE II). Then, the authors extracted and categorized suggestions according to Population, Intervention, Professions, Outcomes and Health care setting (PIPOH). The decision-making process was based on systemic evaluation of each suggestion, utilizing a combination of AGREE II scores, the quality of supporting evidence for or against each suggestion and the triad of feasibility, acceptance and adoptability for the Iranian health-care context.
RESULTS: Two guidelines were included in the adaptation process. Based on high-quality of these guidelines and the feasibility and adoptability evaluation of the organizing committee, we decided to adopt the suggestion of both guidelines. Overall, seven suggestions were extracted from the source guidelines.
CONCLUSION: This work provides a framework to apply guidelines for acute SCI to the developing regions of the world. Attempts should be made to implement these suggestions in order to improve the health outcomes of Iranian SCI patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
|---|---|
| Enthalten in: |
Archives of Iranian medicine - 25(2022), 6 vom: 01. Juni, Seite 353-359 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jazayeri, Seyed Behnam [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Clinical practice guideline |
|---|
| Anmerkungen: |
Date Completed 10.08.2022 Date Revised 15.08.2022 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.34172/aim.2022.58 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM344624307 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM344624307 | ||
| 003 | DE-627 | ||
| 005 | 20231226023214.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.34172/aim.2022.58 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1148.xml |
| 035 | |a (DE-627)NLM344624307 | ||
| 035 | |a (NLM)35943014 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Jazayeri, Seyed Behnam |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Adopting Clinical Practice Guidelines for Pharmacologic Management of Acute Spinal Cord Injury from a Developed World Context to a Developing Global Region |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.08.2022 | ||
| 500 | |a Date Revised 15.08.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons. org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | ||
| 520 | |a BACKGROUND: Proper utilization of high-quality clinical practice guidelines (CPGs) eliminates the dependence of patients' outcomes on the ability and knowledge of "individual" health care providers and reduces unwarranted variation in care. The aim of this study was to adapt/adopt two CPGs for pharmacologic management of acute spinal cord injury (SCI) using guideline adaptation methods | ||
| 520 | |a METHODS: This study was conducted based on the ADAPTE process. Following establishment of an organizing committee and choosing the health topics, we appraised the quality of the CPGs using the Appraisal of Clinical Guidelines for Research & Evaluation II (AGREE II). Then, the authors extracted and categorized suggestions according to Population, Intervention, Professions, Outcomes and Health care setting (PIPOH). The decision-making process was based on systemic evaluation of each suggestion, utilizing a combination of AGREE II scores, the quality of supporting evidence for or against each suggestion and the triad of feasibility, acceptance and adoptability for the Iranian health-care context | ||
| 520 | |a RESULTS: Two guidelines were included in the adaptation process. Based on high-quality of these guidelines and the feasibility and adoptability evaluation of the organizing committee, we decided to adopt the suggestion of both guidelines. Overall, seven suggestions were extracted from the source guidelines | ||
| 520 | |a CONCLUSION: This work provides a framework to apply guidelines for acute SCI to the developing regions of the world. Attempts should be made to implement these suggestions in order to improve the health outcomes of Iranian SCI patients | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Clinical practice guideline | |
| 650 | 4 | |a Pharmacologic management | |
| 650 | 4 | |a Spinal cord injury | |
| 700 | 1 | |a Maroufi, Seyed Farzad |e verfasserin |4 aut | |
| 700 | 1 | |a Ghodsi, Zahra |e verfasserin |4 aut | |
| 700 | 1 | |a Ghawami, Heshmatollah |e verfasserin |4 aut | |
| 700 | 1 | |a Pourrashidi, Ahmad |e verfasserin |4 aut | |
| 700 | 1 | |a Amirjamshidi, Abbas |e verfasserin |4 aut | |
| 700 | 1 | |a Mojtahedzadeh, Mojtaba |e verfasserin |4 aut | |
| 700 | 1 | |a Arabkheradmand, Jalil |e verfasserin |4 aut | |
| 700 | 1 | |a Farahbakhsh, Farzin |e verfasserin |4 aut | |
| 700 | 1 | |a Shabany, Maryam |e verfasserin |4 aut | |
| 700 | 1 | |a Faghih-Jouibari, Morteza |e verfasserin |4 aut | |
| 700 | 1 | |a Fehlings, Michael G |e verfasserin |4 aut | |
| 700 | 1 | |a Kwon, Brian K |e verfasserin |4 aut | |
| 700 | 1 | |a Harrop, James S |e verfasserin |4 aut | |
| 700 | 1 | |a Rahimi-Movaghar, Vafa |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Archives of Iranian medicine |d 2006 |g 25(2022), 6 vom: 01. Juni, Seite 353-359 |w (DE-627)NLM162330294 |x 1735-3947 |7 nnns |
| 773 | 1 | 8 | |g volume:25 |g year:2022 |g number:6 |g day:01 |g month:06 |g pages:353-359 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.34172/aim.2022.58 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 25 |j 2022 |e 6 |b 01 |c 06 |h 353-359 | ||